Molcure Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Later Stage VC
- Investors
-
9
Molcure General Information
Description
Developer of a bio-pharmaceutical technology intended to assist in drug discovery. The company's services offer users knowledge of next-generation sequencing, bioinformatics, and antibody biology with an automated discovery system, enabling pharmaceutical companies to reduce research and development time.
Contact Information
Website
www.molcure.comCorporate Office
- Airbic A07, 7-7 Shinkawasaki
- Saiwai-ku
- Kawasaki, Kanagawa 212-0032
- Japan
Corporate Office
- Airbic A07, 7-7 Shinkawasaki
- Saiwai-ku
- Kawasaki, Kanagawa 212-0032
- Japan
Molcure Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 07-Oct-2026 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 01-Dec-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 17-Aug-2021 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Dec-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 27-Nov-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 27-Sep-2014 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Jun-2013 | $100K | $211K | Completed | Generating Revenue | |
| 1. Debt - General | 07-Feb-2013 | $110K | $110K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Molcure Patents
Molcure Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-6465407-B2 | Method and system for determining a polypeptide that binds to a target molecule | Active | 22-Nov-2013 | ||
| JP-WO2015076355-A1 | Method and system for determining a polypeptide that binds to a target molecule | Active | 22-Nov-2013 | ||
| JP-6665274-B2 | Method and system for determining polypeptide binding to target molecule | Active | 22-Nov-2013 | ||
| EP-3072976-A1 | Method for determining and system for determining polypeptide bonding to target molecule | Active | 22-Nov-2013 | ||
| EP-3072976-A4 | Method for determining and system for determining polypeptide bonding to target molecule | Active | 22-Nov-2013 | G01N33/6818 |
Molcure Signals
Molcure Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Itochu | Corporation | Minority | ||
| Chiba Dojo | Venture Capital | Minority | ||
| Jafco | Venture Capital | Minority | ||
| Japan Post Capital | Corporate Venture Capital | Minority | ||
| SBI Investment | Venture Capital | Minority |
Molcure FAQs
-
When was Molcure founded?
Molcure was founded in 2013.
-
Where is Molcure headquartered?
Molcure is headquartered in Kawasaki, Japan.
-
What is the size of Molcure?
Molcure has 22 total employees.
-
What industry is Molcure in?
Molcure’s primary industry is Enterprise Systems (Healthcare).
-
Is Molcure a private or public company?
Molcure is a Private company.
-
What is Molcure’s current revenue?
The current revenue for Molcure is .
-
How much funding has Molcure raised over time?
Molcure has raised $12M.
-
Who are Molcure’s investors?
Itochu, Chiba Dojo, Jafco, Japan Post Capital, and SBI Investment are 5 of 9 investors who have invested in Molcure.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process